Population
cGMP-dependent protein kinase (PKG)-knockout mouse platelets and human platelets
Design
Preclinical
Authors
Loading...
p38 inhibition may attenuate aggregation in animal platelets; leaves open translation to human antithrombotic strategies.
This study delineates a novel signaling pathway in platelets where agonists sequentially activate PKG, p38, and ERK to induce integrin activation and aggregation.
Li et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: